University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Ischaemic Pre-Conditioning in Elective Percutaneous Coronary Intervention (PCI) Patients

Phase 1

Conditions: Coronary Artery Disease

Interventions: Device: Angioplasty balloon

First Posted Date: 2008-10-03

Last Posted Date: 2008-10-03

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 20

Registration Number: NCT00765908

Lifestyle Intervention Targetting Obesity and Insulin Resistance in Chronic Hepatitis C

Not Applicable

Completed

Conditions: Obesity
Insulin Resistance
Metabolic Syndrome
Hepatitis C

Interventions: Other: Lifestyle intervention

First Posted Date: 2008-09-19

Last Posted Date: 2011-09-22

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 24

Registration Number: NCT00755742

Locations: 🇨🇦
Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada

Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast Ca

Completed

Conditions: Locally Advanced Breast Cancer
Breast Cancer

First Posted Date: 2008-09-19

Last Posted Date: 2018-02-28

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 120

Registration Number: NCT00756132

Locations: 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada

Acceleration of Recovery From General Anesthesia - Efficacy of Isocapnic Hyperpnoea in Obese Patients Undergoing Isoflurane Anesthesia

Not Applicable

Completed

Conditions: Recovery Time From Isoflurane Anesthesia in Obese Patients

Interventions: Other: Isocapnic Hyperpnoea

First Posted Date: 2008-09-15

Last Posted Date: 2011-04-20

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 44

Registration Number: NCT00752492

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)

Phase 2

Terminated

Conditions: Chronic Lymphocytic Leukaemia

Interventions: Drug: Lenalidomide

First Posted Date: 2008-09-11

Last Posted Date: 2016-06-16

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 27

Registration Number: NCT00751296

Locations: 🇨🇦
University Health Network - Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance

Phase 2

Completed

Conditions: Cancer of the Prostate
Prostatic Neoplasms
Prostate Cancer

Interventions: Dietary Supplement: Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin E
Drug: Placebo

First Posted Date: 2008-09-01

Last Posted Date: 2018-02-14

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 16

Registration Number: NCT00744549

Locations: 🇨🇦
University Health Network - Princess Margaret Hospital, Toronto, Ontario, Canada

Pap Smear Research Study

Not Applicable

Completed

Conditions: Cervical Cancer

Interventions: Other: Diagnostic cervical cancer screening tests (Pap smear, HPV and/or p16)

First Posted Date: 2008-08-29

Last Posted Date: 2018-02-22

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 1712

Registration Number: NCT00743626

Locations: 🇨🇦
University Health Network - Toronto Western Hospital, Toronto, Ontario, Canada

A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer

Phase 1

Completed

Conditions: Head and Neck Cancer

Interventions: Drug: ABI-007

First Posted Date: 2008-08-11

Last Posted Date: 2016-06-22

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 12

Registration Number: NCT00731380

Locations: 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada

The Effects of Glucose/Ischemic Preconditioning on Reperfusion Injury in Deceased-Donor Liver Transplantation

Phase 3

Terminated

Conditions: Liver Transplantation

Interventions: Procedure: Glucose/Ischemic Preconditioning Pre-treatment

First Posted Date: 2008-07-18

Last Posted Date: 2014-07-25

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 50

Registration Number: NCT00718575

Locations: 🇨🇦
University Health Network (Toronto General Hospital), Toronto, Ontario, Canada

Carbon Dioxide Insufflation on Cerebral Microemboli

Phase 2

Terminated

Conditions: Cardiovascular Disease
Mitral Valve Repair
Cerebral Microemboli
Cognitive Decline

Interventions: Procedure: Carbon dioxide insufflation

First Posted Date: 2008-07-15

Last Posted Date: 2011-10-26

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 20

Registration Number: NCT00715845

Locations: 🇨🇦
Toronto General Hospital/ University Health Network, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy